Various immune invasion strategies can impact MHC (major histocompatibility test) class I/peptide presentation and the differentiation, production, migration, survival, and proliferation of particular cytotoxic T cell clones, which can select cancer cells during tumor progression. The gene discussed is HLA-C; the disease is neoplasm.